PA
EZPW icon

PharVision Advisers’s Ezcorp Inc EZPW Stock Holding History

PharVision Advisers’s Portfolio EZPW Stock Details EZPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,062
Closed -$237K – 707
2025
Q2 		$237K Sell
17,062
-6,941
-29% -$100K 0.34% 153
2025
Q1 		$353K Buy
+24,003
New +$317K 0.49% 69

Other funds holding EZPW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

PharVision Advisers's EZPW Position: Q3 2025 in Review

PharVision Advisers sold out of Ezcorp Inc (EZPW) in Q3 2025, closing a stake of 17,062 shares — an estimated $237K sold.

PharVision Advisers first reported a position in EZPW in Q1 2025 and held it in 2 quarters. The position peaked at $353K in Q1 2025. 245 funds tracked by Wall St. Rank hold EZPW as of Q3 2025.

  • PharVision Advisers reported no remaining Ezcorp Inc position as of Q3 2025 after selling out during the quarter.
  • PharVision Advisers sold 17,062 Ezcorp Inc shares in Q3 2025, an estimated $237K.
  • PharVision Advisers first reported a position in Ezcorp Inc in Q1 2025 and held it in 2 quarters.
  • PharVision Advisers's Ezcorp Inc position peaked at $353K in Q1 2025.
  • 245 funds tracked by Wall St. Rank held Ezcorp Inc as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.